For example, miR-124 could inhibit the growth of glioblastoma by downregulating SOS1 [43], radio-sensitizing human glioma cells by targeting CDK4 [53], and suppressing the migration and invasion of glioma cells via Capn4 [54] and ROCK1 [55]. This evidence concerns the gene CDK4 and central nervous system cancer.